ANGUS Chemical Company
Victor Sarantschin is an experienced professional in business development and account management within the biopharmaceutical sector. Currently serving as the Sr. Account Manager and Global Licensing Lead at Advancion Corporation since April 2023, Victor is responsible for business development of ANGUS' Buffer and Biochemicals for pharma and biotech applications and leads global licensing for Expression Systems. Previously, Victor held positions including Director of Business Development at Curia, focusing on large molecules and mRNA in the Western US, and Business Development and Licensing Specialist at Lonza, where responsibilities included the licensing of gene expression technologies. Victor's extensive experience also includes senior roles at ANGUS/Dow Chemical Company, Dow, Neose Technologies, and Tosoh Bioscience, contributing to a strong background in the commercialization and technical marketing of bioprocessing technologies.
This person is not in any offices
ANGUS Chemical Company
ANGUS is a global specialty and fine chemical company dedicated to the development of novel chemistries that deliver enhanced product and process performance across a wide range of applications in pharmaceuticals, biotechnology, paints and coatings, agriculture, personal care, metalworking fluids, electronics and other industrial markets. Thecompany innovates through its unique nitroalkane chemistries, including its flagship AMP™ (aminomethyl propanol) multifunctional additives and TRIS AMINO™ tromethamine, which are produced at fully integrated, ISO 9001-certified manufacturing facilities in Sterlington, Louisiana, USA, and Ibbenbüren, Germany. ANGUS serves its global customers through six regional Customer Applications Centers located in Chicago, Illinois; Paris, France; São Paulo, Brazil; Singapore; Shanghai, China; and Mumbai, India.